The upward trend continued this month with catalysts being the tax plan and holiday sales. My guess remains that the first half of 2018 will be good for corporations (i.e., dividends and buybacks) with a shift in focus later with deficits and mid-term elections playing a leading role. I remain convinced the yearlong weakness in the US Dollar will continue and expect to allocate more cash into foreign equities during the first half 2018. I will review this plan as my personal tax implications become clearer. For the month, the S&P index increased by .98% while my portfolio increased by 3.29% largely fueled by Financials (again). For the year the S&P increased by a stellar 16.26% while I came in at +20.58%! The S&P return with all dividends reinvested adds about 2.41% which my hybrid approach still beat.
April brought more noise to the market with geopolitical issues front and center. The market appeared to acknowledge the fact that even with Republican control of government, a more centrist approach is necessary to accomplish much of anything. The President’s first 100 days ended with one legislative win; a Supreme Court Justice. As earnings season kicked into high gear and the French election completed (runoff pending), the markets rebounded and the S&P ended the month with a .91% gain. Including new money (mostly IRA maximization), my gain was 3.41% (2.32% excluding new money).
The forced move from the Loyal3 platform is essentially complete. Full shares arrived at Schwab April 27th. Fractionals did not move – basically a he said/she said scenario. Schwab says they would accept them while Loyal3 said they wouldn’t. All fractional shares on Loyal3 were sold April 28th, netting $218.59. Loyal3 was basically my ‘spare change’ broker and illustrates the benefits of investing even small amounts. The trades will settle Wednesday and Friday I’ll transfer remaining funds – after I see which direction the YUM dividend goes.
I decided to use Schwab’s synthetic DRIP for PEP, DIS, SBUX, KO and HAS to mitigate the sting of having to sell shares – even fractionals. I’ll take the cash on YUM, AMC, AAPL and K.
Headlines impacting my portfolio (bold are owned):
- 4/3 – IBTX closes Carlile merger
- 4/4 – NJR/SJI discuss merger
- 4/4 – MSGN discusses sale
- 4/7 – JNS merger date expected 5/30/2017 new ticker expected to be JHG w/ qtrly divs
- 4/10 – UNIT acquires Southern Light (pvt)
- 4/17 – CCI to acquire Wilcon Holdings
- 4/17 – BX acquires Eagle Claw Midstream
- 4/20 – UMBF sells institutional investment arm to RJF
- 4/20 – SLF acquires Premier Dental
- 4/24 – NWBI to close consumer finance subsidiary
- 4/27 –TOWN to acquire PBNC,
- 4/27 – IVZ to acquire Source UK
- Added to JNS
- Added to VALU
- Initiated position in PWCDF
- Initiated position in ARD
- Initiated position in HOMB
- Sold LB
- Sold UL
- Reduced (fractional positions) YUMC, SBUX, PEP, K, YUM, DIS, SQ, KO, AMC, AAPL, HAS
- April delivered an increase of 32.55% over April 2016. 17.25% of this increase is attributable to purchases, 48.41% a result of semi-annual cycles (Ireland, Australia) and the remaining 35.51% a result of dividend increases.
- April had an increase of 20.28% over the prior quarter due primarily to the same reasons.
- Declared dividend increases averaged 8.72% with 42.94% of my portfolio delivering at least one raise (including 2 cuts – YUM, XRX).
- YTD Dividends received were 38.1% of total 2016 dividends. If the current run rate is maintained would exceed 2016 in early November – particularly with most of my semi-annual or interim/final cycles paying during the next quarter.
The MET spin (Brighthouse Financial – BHF) remains pending.
Agrium/POT, JNS/HGG.L (estimated completion 30 May) andremain pending. I did add to JNS and HOMB as both appeared undervalued versus the merger price.
Every now and again you wind up getting what you pay for and there’s no such thing as a free lunch. I probably came to this realization last summer when I ensured that even my smallest holding on the Loyal3 platform had greater than a fractional share. So the news this week of their migration to FolioFirst was no big surprise. The issue I have with FolioFirst is the $5 monthly fee. So transferring my holdings becomes priority one. In fact Dividend Growth Investor lays out the options fairly succinctly in his post.
Early on, my strategy with Loyal3 was twofold:
- Move three horses to the platform to generate enough dividends to play with. This was accomplished with PEP, AAPL and SBUX.
- Build a group of speculative holdings (less than 1% portfolio weighting) via dividends generated by the first goal.
The free trades with Loyal3 accelerated this process. Today I’m faced with a (slight) strategy shift.
An order was placed this morning to sell Unilever (UL) and L Brands (LB). Unilever due to taking profits off the table and for a sense of protection from a potential single headquarter location and the possible corresponding tax implications. L Brands due to uncertainty with their ability to maintain comps while the malls where their stores are located appear to be imploding. I’ll use this as a tax loss against UL and the required fractional share sales.
My remaining Loyal3 full share holdings (YUM, YUMC, AAPL, K, SBUX, HAS, DIS, SQ, PEP, KO and AMC) will be moved … Loyal3 will not move fractionals which will need to be sold. My goal is to have the transfer complete prior to May 1st which is the ex-div date for the next payer, Hasbro. I can then sell any remaining fractionals, wait for YUM’s dividend to post (May 5th, went ex-div April 14th), then move any cash into my bank.
My default approach will be to consolidate the holdings into my existing brokerage account which provides the alternative to reinvest dividends. I will, however, meet with TD Ameritrade today as they (via phone conversations) have indicated they perform OTC ‘grey market’ trades with no surcharge. As Schwab charges a $50 surcharge, this may clinch the deal for AMTD.
So any Loyal3 strategy shifts in your future?
Update: 20 Apr 2017 – UL and LB sold, decision finalized on move of remaining to existing Schwab account. AMTD has no set ‘grey market’ policy but will normally adjust the fee. Lack of certainty killed this option.
February saw DOW 20,000 being attained (again) then forging a streak of 12 days of record closes. Uncertainty remains in areas of the ability or time required to effect change through the legislative process – in particular tax reform, healthcare and border adjustment taxes. This month The S&P gained 3.72%. while my portfolio recorded a gain of 0.05%. The index had a decent earnings season (until TGT) as its tailwind. After two months, my performance lags the S&P by 1.95%.
Headlines impacting my portfolio:
- 2/6 – BUSE acquiring FCFP
- 2/7 – AMC prices secondary
- 2/10 – BX buys AON HR assets
- 2/14 – PYPL buys TNCGF
- 2/17 – KHC announced pursuit of UL
- 2/21 – PNC acquires US assets of ECNCF
- 2/21 – JNJ buys Torax (pvt)
posts under consideration for Mar are My 2017 Coca-Cola strategy outlined
- Added to LB prior to ex-div (a little gamble on earnings that failed)
- Added to SBUX on weakness prior to ex-div
- Added to CHD prior to ex-div and the day before the UL/KHC sector bump
Subsequent to the KHC/UL announcement, I made the determination to divest my UL holdings. Unfortunately over the holiday weekend the offer was withdrawn so my opportunity to sell at a premium evaporated. So – no sale.
- February delivered an increase of 24.89% over February 2016. 12.96% of this increase is attributable to purchases with the remaining 87.04% a result of dividend increases.
- February was flat over the prior quarter (actually $0.01 lower due to exchange rates and a cut).
- Declared dividend increases averaged 8.06% with 30.64% of my portfolio delivering at least one raise (1 cut – YUM).
- Dividends received were 14.3% of total 2016 dividends and if the current run rate is maintained would exceed 2016 around October 15th.
The MET spin (Brighthouse Financial – BHF) remains pending.
Agrium/POT, JNS/HGG.L remain pending
Last month the sky was falling primarily on Brexit concerns. Just a few short weeks later, the S&P and DOW are setting all time records. Similarly you can choose a Cleveland view of the US economy (“it’s on the cusp of a recession”) or the Philadelphia view (“Tremendous progress has been achieved”). Sadly reality probably sits squarely in between. Meanwhile, I’m keeping an eye on Italian banks. For good measure, the S&P outperformed my portfolio for the first time this year – 3.56% vs 3.0%. For the year though, I’m ahead by 11.65%. Headlines related to my portfolio this month include:
ConocoPhillips (COP) announced a 66% dividend cut this morning. Probably not a major surprise to anyone. Even D4L, who published an analysis on Feb 2, was cautious in his outlook. At least the markets’ reaction was normal – giving the stock about a 8.5% haircut, although I’m sure this is little solace to the roughly 70 members of the DGI community that hold it.